Amphastar Pharmaceuticals
AMPH
AMPH
134 hedge funds and large institutions have $442M invested in Amphastar Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 46 increasing their positions, 36 reducing their positions, and 6 closing their positions.
Holders
134
Holders Change
+26
Holders Change %
+24.07%
% of All Funds
2.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
46
Reduced
36
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
MSL
1
Mackay Shields LLC
New York
|
$1.65M |
| 2 |
2
Goldman Sachs
New York
|
$2.5M |
| 3 |
3
BlackRock
New York
|
$118M |
| 4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.51M |
| 5 |
5
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
$2.34M |
